https://www.selleckchem.com/pr....oducts/senaparib.htm
rs. We believe that this condition likely has a greater prevalence than what is reported and that improved recognition will lead to improved outcomes. To evaluate a case of pembrolizumab-induced hypoparathyroidism leading to hypocalcemia. The diagnostic tests performed included calcium and parathyroid hormone level detection and calcium-sensing receptor gene analysis. A 71-year-old Caucasian man was diagnosed with stage IIIB adenocarcinoma of the lung and received radiation therapy but had no other exposure to radiation. Pembrolizumab